from web site
For general details, Learn more about Scientific Research Studies. pulmonary infection treatment for eligibility information Ages Eligible for Study: 18 Years to 80 Years (Grownup, Older Grownup )Sexes Eligible for Study: All Accepts Healthy Volunteers: No Addition Criteria: Solid advanced deadly growths Age between18 and 80 years Life expectancy is greater than three months Exemption Criteria: Benign growth Life expectancy is less than three months Severe medical comorbidity Others Go to To discover more about this study, you or your physician may contact the research study research staff utilizing the contact information offered by the sponsor. gov identifier( NCT number ): Layout table for area info The 2nd Affiliated Medical Facility of Guangzhou Medical University Guangzhou, Guangdong, China, 510260 Contact: Zhenfeng Zhang, MD, Ph, D +862039195966 zhangzhf@gzhmu. edu.cn Contact: Bingjia He, MD +862039195965 464677938@qq. com Second Affiliated Healthcare Facility of Guangzhou Medical University Guangdong Zhaotai In
, Vivo Biomedicine Co. Design table for private investigator info Principal Investigator: Zhenfeng Zhang, MD, Ph, D 2nd Affiliated Healthcare Facility of Guangzhou Medical University Go to Design table for additonal info Accountable Celebration: Second Affiliated Medical Facility of Guangzhou Medical University Medical, Trials. gov Identifier: Other Research Study ID Numbers: Cp, G-ODN on growths Very first Posted: July 7, 2021 Key Record Dates Last Update Posted: July 7, 2021 Last Verified: June 2021 Person Individual Data( IPD )Sharing Declaration: Strategy to Share IPD: No Design table for extra details Studies a U.S. FDA-regulated Device Item: No Additional appropriate Me, SH terms: Design table for Me, SH terms Carcinoma, Hepatocellular, Neoplasms, Adenocarcinoma, Carcinoma, Neoplasms, Glandular and Epithelial, Neoplasms by Histologic Type, Liver Neoplasms, Digestive System Neoplasms Neoplasms by Website, Digestive System Diseases, Liver Illness, CPG-oligonucleotide, Adjuvants, Immunologic, Immunologic Elements, Physiological Impacts of Drugs. For this factor, they are constantly used in addition to other tests. In breast cancer care, 3 tumor markers-- cancer antigen 15-3( CA 15-3), cancer antigen 27. 29( CA 27. 29 ), and carcinoembryonic antigen( CEA)-- have actually been utilized to help keep track of metastatic breast cancer( advanced disease), but they have actually not been discovered to be helpful to find a breast cancer reoccurrence or extend lives in clients who had early-stage breast cancer and who are now disease-free.